XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Note 12 - Fair Value Measurements and Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

12. Fair Value Measurements and Fair Value of Financial Instruments

 

The Company uses fair value to measure certain assets and liabilities on a recurring basis, primarily securities available-for-sale and derivatives. For assets measured at the lower of cost or fair value, the fair value measurement criteria may or may not be met during a reporting period and such measurements are therefore considered “nonrecurring” for purposes of disclosing our fair value measurements. Fair value is used on a nonrecurring basis to adjust carrying values for individually evaluated loans and other real estate owned and also to record impairment on certain assets, such as goodwill, CDI, and other long-lived assets.

 

The Company used valuation methodologies to measure assets at fair value under ASC Topic 820 and ASC Topic 825, as amended by ASU 2016-01 and ASU 2018-03, to estimate the fair value of financial instruments not recorded at fair value. The fair value of the Company’s assets and liabilities is classified and disclosed in one of the following three categories:

 

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Observable prices in active markets for similar assets or liabilities; prices for identical or similar assets or liabilities in markets that are not active; directly observable market inputs for substantially the full term of the asset and liability; market inputs that are not directly observable but are derived from or corroborated by observable market data.

 

Level 3 – Unobservable inputs based on the Company’s own judgment about the assumptions that a market participant would use.

 

The classification of assets and liabilities within the hierarchy is based on whether inputs to the valuation methodology used are observable or unobservable, and the significance of those inputs in the fair value measurement. The Company’s assets and liabilities are classified in their entirety based on the lowest level of input that is significant to their fair value measurements.

 

Financial assets and liabilities measured at fair value on a recurring basis:

 

The Company uses the following methodologies to measure the fair value of its financial assets and liabilities on a recurring basis:

 

Securities Available-for-Sale and Equity Securities - For certain actively traded agency preferred stocks, mutual funds, U.S. Treasury securities, and other equity securities, the Company measures the fair value based on quoted market prices in active exchange markets at the reporting date, a Level 1 measurement. The Company also measures securities by using quoted market prices for similar securities or dealer quotes, a Level 2 measurement. This category generally includes U.S. Government agency securities, U.S. Government sponsored entities, state and municipal securities, mortgage-backed securities (“MBS”), collateralized mortgage obligations and corporate bonds.

 

Warrants - The Company measures the fair value of warrants based on unobservable inputs based on assumptions and management judgment, a Level 3 measurement.

 

Interest Rate Swaps – The Company measures the fair value of interest rate swaps using third party models with observable market data, a Level 2 measurement.

 

Currency Option Contracts and Foreign Exchange Contracts - The Company measures the fair value of currency option contracts and foreign exchange contracts based on observable market rates on a recurring basis, a Level 2 measurement.

 

The following tables present financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023:

 

  

March 31, 2024

     
  

Fair Value Measurements Using

  

Total Fair Value

 
  

Level 1

  

Level 2

  

Level 3

  

Measurements

 
  

(In thousands)

 

Assets

                

Securities AFS

                

U.S. Treasury securities

 $541,798  $  $  $541,798 

U.S. government agency entities

     12,058      12,058 

U.S. government sponsored entities

     59,745      59,745 

Mortgage-backed securities

     754,162      754,162 

Collateralized mortgage obligations

     27,198      27,198 

Corporate debt securities

     258,206      258,206 

Total securities AFS

  541,798   1,111,369      1,653,167 
                 

Equity securities

                

Mutual funds

  5,526         5,526 

Preferred stock of government sponsored entities

  2,384         2,384 

Other equity securities

  23,470         23,470 

Total equity securities

  31,380         31,380 
                 

Interest rate swaps

     55,138      55,138 

Foreign exchange contracts

     334      334 

Total assets

 $573,178  $1,166,841  $  $1,740,019 
                 

Liabilities

                

Interest rate swaps

 $  $42,014  $  $42,014 

Foreign exchange contracts

     186      186 

Total liabilities

 $  $42,200  $  $42,200 

 

  

December 31, 2023

     
  

Fair Value Measurements Using

  

Total Fair Value

 
  

Level 1

  

Level 2

  

Level 3

  

Measurements

 
  

(In thousands)

 

Assets

                

Securities AFS

                

U.S. Treasury securities

 $495,300  $  $  $495,300 

U.S. government agency entities

     48,169      48,169 

Mortgage-backed securities

     786,723      786,723 

Collateralized mortgage obligations

     28,044      28,044 

Corporate debt securities

     246,334      246,334 

Total securities AFS

  495,300   1,109,270      1,604,570 
                 

Equity securities

                

Mutual funds

  5,585         5,585 

Preferred stock of government sponsored entities

  1,821         1,821 

Other equity securities

  33,000         33,000 

Total equity securities

  40,406         40,406 
                 

Interest rate swaps

     54,268      54,268 

Foreign exchange contracts

     379      379 

Total assets

 $535,706  $1,163,917  $  $1,699,623 
                 

Liabilities

                

Interest rate swaps

 $  $45,762  $  $45,762 

Foreign exchange contracts

     175      175 

Total liabilities

 $  $45,937  $  $45,937 

 

Financial assets and liabilities measured at estimated fair value on a non-recurring basis:

 

Certain assets or liabilities are required to be measured at estimated fair value on a nonrecurring basis subsequent to initial recognition. Generally, these adjustments are the result of lower-of-cost-or-fair value or other impairment write-downs of individual assets. In determining the estimated fair values during the period, the Company determined that substantially all the changes in estimated fair value were due to declines in market conditions versus instrument specific credit risk. For the periods ended March 31, 2024, and December 31, 2023, there were no material adjustments to fair value for the Company’s assets and liabilities measured at fair value on a nonrecurring basis in accordance with GAAP.

 

For financial assets measured at fair value on a nonrecurring basis that were still reflected in the Consolidated Balance Sheets as of March 31, 2024, and December 31, 2023, the following tables set forth the level of valuation assumptions used to determine each adjustment, the carrying value of the related individual assets as of March 31, 2024, and December 31, 2023, and the total losses for the periods indicated:

 

  

As of March 31, 2024

  

Total Losses

 
  

Fair Value Measurements Using

  

Total Fair Value

  

For the Three Months Ended

 
  

Level 1

  

Level 2

  

Level 3

  

Measurements

  

March 31, 2024

  

March 31, 2023

 
  

(In thousands)

 

Assets

                        

Non accrual loans by type:

                        

Commercial loans

 $  $  $129  $129  $1,038  $2,793 

Commercial real estate loans

        20,002   20,002   251   3,990 

Total non accrual loans

        20,131   20,131   1,289   6,783 

Other real estate owned (1)

        20,446   20,446       

Investments in venture capital

        93   93       

Total assets

 $  $  $40,670  $40,670  $1,289  $6,783 

 

(1) Other real estate owned balance of $19.4 million in the Consolidated Balance Sheets is net of estimated disposal costs.

 

  

As of December 31, 2023

  

Total Losses

 
  

Fair Value Measurements Using

  

Total Fair Value

  

For the Twelve Months Ended

 
  

Level 1

  

Level 2

  

Level 3

  

Measurements

  

December 31, 2023

  

December 31, 2022

 
  

(In thousands)

 

Assets

                        

Non accrual loans by type:

                        

Commercial loans

 $  $  $191  $191  $  $1,786 

Commercial real estate loans

        6,882   6,882   4,069   2,091 

Total non accrual loans

        7,073   7,073   4,069   3,877 

Other real estate owned (1)

        20,446   20,446       

Investments in venture capital

        237   237   227   268 

Total assets

 $  $  $27,756  $27,756  $4,296  $4,145 

 

(1) Other real estate owned balance of $19.4 million in the Consolidated Balance Sheets is net of estimated disposal costs.

 

The significant unobservable (Level 3) inputs used in the fair value measurement of collateral for collateral-dependent individually evaluated loans are primarily based on the appraised value of collateral adjusted by estimated sales cost and commissions. The Company generally obtains new appraisal reports every twelve months as appropriate. As the Company’s primary objective in the event of default would be to monetize the collateral to settle the outstanding balance of the loan, less marketable collateral would receive a larger discount. In the current year, the Company used borrower specific collateral discounts with various discount levels.

 

The fair value of individually evaluated loans is calculated based on the net realizable fair value of the collateral or the observable market price of the most recent sale or quoted price from loans held for sale. The Company does not record loans at fair value on a recurring basis. Nonrecurring fair value adjustments to collateral dependent individually evaluated loans are recorded based on the current appraised value of the collateral, a Level 2 measurement, or management’s judgment and estimation of value using discounted future cash flows or old appraisals which are then adjusted based on recent market trends, a Level 3 measurement.

 

Loans held for sale are recorded at the lower of cost or fair value upon transfer. Loans held for sale may be measured at fair value on a nonrecurring basis when fair value is less than cost. Fair value is generally determined based on available market data for similar loans and therefore, are classified as Level 2 measurement.

 

The significant unobservable inputs (Level 3) used in the fair value measurement of other real estate owned (“OREO”) are primarily based on the appraised value of OREO adjusted by estimated sales cost and commissions. The Company applies estimated sales cost and commissions ranging from 3% to 6% of the collateral value of individually evaluated loans, quoted price, or loan sale price of loans held for sale, and appraised value of OREO.

 

There were no warrants outstanding as of March 31, 2024, and December 31, 2023.

 

Fair value is estimated in accordance with ASC Topic 825. Fair value estimates are made at specific points in time, based on relevant market information and information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Bank’s entire holdings of a particular financial instrument. Because no market exists for a significant portion of the Bank’s financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments, and other factors. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

The following table sets forth the carrying and notional amounts and estimated fair value of financial instruments as of March 31, 2024, and December 31, 2023:

 

  

March 31, 2024

  

December 31, 2023

 
  

Carrying

      

Carrying

     
  

Amount

  

Fair Value

  

Amount

  

Fair Value

 
  

(In thousands)

 

Financial Assets

                

Cash and due from banks

 $165,284  $165,284  $173,988  $173,988 

Short-term investments

  1,010,651   1,010,651   654,813   654,813 

Securities AFS

  1,653,167   1,653,167   1,604,570   1,604,570 

Loans held-for-sale

  23,171   23,171       

Loans held for investment, net

  19,263,070   19,597,530   19,382,858   19,605,152 

Equity securities

  31,380   31,380   40,406   40,406 

Investment in Federal Home Loan Bank stock

  17,250   17,250   17,746   17,746 

 

  

Notional

      

Notional

     
  

Amount

  

Fair Value

  

Amount

  

Fair Value

 

Foreign exchange contracts

 $250,648  $334  $124,452  $379 

Interest rate swaps

  1,100,019   55,138   1,406,879   54,268 

 

  

Carrying

      

Carrying

     
  

Amount

  

Fair Value

  

Amount

  

Fair Value

 

Financial Liabilities

                

Deposits

 $19,846,259  $19,855,328  $19,325,447  $19,347,070 

Advances from Federal Home Loan Bank

  265,000   264,596   540,000   536,996 

Other borrowings

  17,557   15,373   15,787   13,978 

Long-term debt

  119,136   73,102   119,136   72,304 

 

  

Notional

      

Notional

     
  

Amount

  

Fair Value

  

Amount

  

Fair Value

 

Foreign exchange contracts

 $66,081  $186  $101,378  $175 

Interest rate swaps

  952,560   42,014   1,078,880   45,762 

 

  

Notional

      

Notional

     
  

Amount

  

Fair Value

  

Amount

  

Fair Value

 

Off-Balance Sheet Financial Instruments

                

Commitments to extend credit

 $3,925,285  $(19,052) $3,808,620  $(14,344)

Standby letters of credit

  386,442   (3,031)  368,618   (2,821)

Other letters of credit

  19,450   (17)  11,308   (10)

 

The following tables set forth the level in the fair value hierarchy for the estimated fair values of financial instruments as of March 31, 2024, and December 31, 2023, excluding financial instruments recorded at fair value on a recurring basis already presented in other tables in this note:

 

  

As of March 31, 2024

 
  

Fair Value

  

Level 1

  

Level 2

  

Level 3

 
  

(In thousands)

 

Financial Assets

                

Cash and due from banks

 $165,284  $165,284  $  $ 

Short-term investments

  1,010,651   1,010,651       

Loans held-for-sale

  23,171      23,171    

Loans held for investment, net

  19,597,530         19,597,530 

Equity securities

  31,380   31,380       

Investment in Federal Home Loan Bank stock

  17,250      17,250    

Financial Liabilities

                

Deposits

  19,855,328         19,855,328 

Advances from Federal Home Loan Bank

  264,596      264,596    

Other borrowings

  15,373         15,373 

Long-term debt

  73,102      73,102    

 

  

As of December 31, 2023

 
  

Fair Value

  

Level 1

  

Level 2

  

Level 3

 
  

(In thousands)

 

Financial Assets

                

Cash and due from banks

 $173,988  $173,988  $  $ 

Short-term investments

  654,813   654,813       

Loans held for investment, net

  19,605,152         19,605,152 

Equity securities

  40,406   40,406       

Investment in Federal Home Loan Bank stock

  17,746      17,746    

Financial Liabilities

                

Deposits

  19,347,070         19,347,070 

Advances from Federal Home Loan Bank

  536,996      536,996    

Other borrowings

  13,978         13,978 

Long-term debt

  72,304      72,304